Edition:
India

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

16.61USD
15 Dec 2017
Change (% chg)

$-0.66 (-3.82%)
Prev Close
$17.27
Open
$17.31
Day's High
$17.40
Day's Low
$16.12
Volume
1,228,995
Avg. Vol
402,126
52-wk High
$20.76
52-wk Low
$6.75

Chart for

About

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive... (more)

Overall

Beta: 2.07
Market Cap(Mil.): $2,309.91
Shares Outstanding(Mil.): 113.40
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Corcept Therapeutics posts Q3 earnings per share $0.11

* Corcept Therapeutics announces third quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update

03 Nov 2017

BRIEF-Corcept Therapeutic says Dohmen Life Science Services filed a complaint alleging Corcept unlawfully terminated Dohmen agreement

* Corcept Therapeutics Inc - On August 7, 2017, Dohmen Life Science Services filed a complaint alleging corcept unlawfully terminated dohmen agreement

30 Aug 2017

BRIEF-Corcept Therapeutics Q2 GAAP earnings per share $0.10

* Corcept Therapeutics announces second quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update

02 Aug 2017

Competitors

Earnings vs. Estimates